Variants in the adiponectin gene and serum adiponectin: The coronary artery development in young adults (CARDIA) study

Obesity

Volumn 18, Issue 12, 2010, Pages 2333-2338

  Wassel, Christina L ^a   Pankow, James S ^b   Jacobs, David R ^b,c   Steffes, Michael W ^d   Li, Na ^b   Schreiner, Pamela J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CAUCASIAN; ETHNOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; WAIST CIRCUMFERENCE;

EID: 78649938449     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.85     Document Type: Article

References (32)

1. Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease. Am J Physiol Heart Circ Physiol 2007;292:H1655-H1663.
2. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-45026.
3. Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 2006;12:163-168.
4. Karaduman M, Sengul A, Oktenli C et al. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol (Oxf) 2006;64:196-202.
5. Li CJ, Sun HW, Zhu FL et al. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J Endocrinol 2007;193:137-145.
6. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1-12.
7. Pischon T, Girman CJ, Hotamisligil GS et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737.
8. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006;48:1369-1377.
9. Hashimoto N, Kanda J, Nakamura T et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metab Clin Exp 2006;55:1653-1657.
10. Frystyk J, Berne C, Berglund L et al. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007;92:571-576.
11. Sattar N, Wannamethee G, Sarwar N et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006;114:623-629.
12. Kanaya AM, Wassel Fyr C, Vittinghoff E et al.; Health ABC Study. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 2006;91:5044-5050.
13. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007;165:164-174.
14. Schnabel R, Messow CM, Lubos E et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008;29:649-657.
15. Steffes MW, Gross MD, Lee DH, Schreiner PJ, Jacobs DR Jr. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 2006;14:319-326.
16. Kadowaki T, Yamauchi T, Kubota N et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-1792.
17. Hermann TS, Li W, Dominguez H et al. Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. J Clin Endocrinol Metab 2006;91: 1001-1008.
18. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007;56:1198-1209.
19. Jang Y, Lee JH, Chae JS et al. Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005;82:760-767.
20. Qi L, Li T, Rimm E et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005;54:1607-1610.
21. Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002;11:2607-2614.
22. Heid IM, Wagner SA, Gohlke H et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006;55:375-384.
23. Hoefle G, Muendlein A, Saely CH et al. The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost 2007;97:451-457.
24. Filippi E, Sentinelli F, Romeo S et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
25. Hughes GH, Cutter G, Donahue R et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control Clin Trials 1987;8:68S-73S.
26. Carlson CS, Eberle MA, Rieder MJ et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120.
27. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
28. Avery CL, Martin LJ, Williams JT, North KE. Accuracy of haplotype estimation in a region of low linkage disequilibrium. BMC Genet 2005;6 Suppl 1:S80.
29. Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008;6:87-102.
30. Efstathiou S P, Skeva II, Dimas C et al. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis 2009;205:632-636.
31. Otsuka F, Kojima S, Maruyoshi H et al. Smoking cessation is associated with increased plasma adiponectin levels in men. J Cardiol 2009;53:219-225.
32. Ying S Y, Lin SL. Intron-derived microRNAs-fine tuning of gene functions. Gene 2004;342:25-28.